Veribo GM 2mg/500mg/0.2mg Tablet
Marketer
Tulsi Medi Sciences
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Veribo GM 2mg/500mg/0.2mg Tablet
Diabeva Trio 2mg/500mg/0.2mg tablets are classified as antidiabetic medications. This combination therapy is indicated for managing type 2 diabetes in adults, effectively regulating blood glucose. Diabeva Trio should be administered with meals, consistently at the same time daily for optimal results. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is part of a comprehensive diabetes management plan, including a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, lightheadedness, headache, and tremors. Learn to recognize and manage these symptoms; maintain regular mealtimes and carry a readily available fast-acting sugar source, such as glucose tablets or juice. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, swelling (edema), blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Inform your doctor of any history of heart disease before commencing treatment; it may not be appropriate in all cases. Pregnant or lactating women should consult their physician prior to use. Regular blood glucose monitoring is essential, along with potential blood tests to assess blood cell counts and liver function.
Uses of Veribo GM 2mg/500mg/0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Veribo GM 2mg/500mg/0.2mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Veribo GM 2mg/500mg/0.2mg Tablet on an empty stomach.
Common Side effects of Veribo GM 2mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Veribo GM 2mg/500mg/0.2mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Veribo GM 2mg/500mg/0.2mg Tablets should be taken on an empty stomach.
How Veribo GM 2mg/500mg/0.2mg Tablet works:
A single tablet of Veribo GM contains 2mg, 500mg, and 0.2mg of three distinct anti-diabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Veribo GM 2mg/500mg/0.2mg Tablet with alcohol poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Veribo GM 2mg/500mg/0.2mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Veribo GM 2mg/500mg/0.2mg Tablets while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Patients with kidney disease should likely avoid Veribo GM 2mg/500mg/0.2mg Tablets due to potential safety concerns. Medical advice is recommended. The use of Veribo GM 2mg/500mg/0.2mg Tablets is contraindicated in individuals with severe kidney impairment.
LiverCAUTION
Patients with liver impairment should use Veribo GM 2mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. A low initial dose is typically prescribed for individuals with mild to moderate liver disease; however, its use is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Veribo GM 2mg/500mg/0.2mg Tablet :
Should you forget to take a Veribo GM 2mg/500mg/0.2mg Tablet, administer it immediately if remembered. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Veribo GM 2mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently